A open-label study to compare the efficacy and tolerability of aripiprazole and risperidone in the treatment of children with autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD).

Trial Profile

A open-label study to compare the efficacy and tolerability of aripiprazole and risperidone in the treatment of children with autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD).

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Oct 2015

At a glance

  • Drugs Aripiprazole (Primary) ; Risperidone (Primary)
  • Indications Attention-deficit hyperactivity disorder; Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Oct 2015 Results published on 28th Annual Congress of the European College of Neuropsychopharmacology
    • 26 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top